Coronary angiography with Iopamidol.

Area of Science:

• Cardiology
• Radiology
• Pharmacology

Background:

• Non-ionic contrast media offer improved safety profiles in cardiovascular imaging.
• Low-osmolality contrast agents aim to minimize hemodynamic and electrocardiographic disturbances.
• Selective coronary angiography requires contrast agents with excellent tolerability.

Purpose of the Study:

• To compare the safety and efficacy of Iopamidol versus Isopaque Coronar in selective coronary angiography.
• To evaluate hemodynamic and electrocardiographic effects of Iopamidol in patients undergoing coronary angiography.

Main Methods:

• A comparative study involving 16 patients undergoing selective coronary angiography.
• Assessment of hemodynamic parameters (blood pressure) and electrocardiographic (ECG) changes.
• Monitoring for subjective adverse effects reported by patients.

Main Results:

• Iopamidol administration resulted in significantly less bradycardia compared to Isopaque Coronar.
• Fewer electrocardiographic (ECG) changes were observed with Iopamidol.
• A smaller decrease in blood pressure was noted with Iopamidol.
• No subjective adverse events, including chest pain or nausea, were reported with Iopamidol.

Conclusions:

• Iopamidol exhibits a superior safety profile for selective coronary angiography.
• The low-osmolality, non-ionic properties of Iopamidol contribute to enhanced patient tolerance.
• Iopamidol presents a promising alternative contrast medium for cardiac procedures.